Notices. 30-day notice of information collection under review: Application for individual manufacturing quota for a basic class of controlled substance and for ephedrine, pseudoephedrine, and phenylpropanolamine DEA Form189

10,031 words·~46 min read·/register/2007/08/24/07-4141

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4410-11-M DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117-0006] Agency Information Collection Activities: Proposed Collection; Comments Requested ACTION: 30-day notice of information collection under review: Application for individual manufacturing quota for a basic class of controlled substance and for ephedrine, pseudoephedrine, and phenylpropanolamine DEA Form189. The Department of Justice (DOJ), Drug Enforcement Administration

(DEA)will be submitting the following information collection request to the Office of Management and Budget

(OMB)for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the **Federal Register** Volume 72, Number 117, page 33774 on June 19, 2007, allowing for a 60 day comment period. The purpose of this notice is to allow for an additional 30 days for public comment until September 24, 2007. This process is conducted in accordance with 5 CFR 1320.10. Written comments and/or suggestions regarding the items contained in this notice, especially the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503. Additionally, comments may be submitted to OMB via facsimile to

(202)395-5806. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection

(1)*Type of Information Collection:* Extension of an existing collection.

(2)*Title of the Form/Collection:* Application for Individual Manufacturing Quota for a Basic Class of Controlled Substance and for Ephedrine, Pseudoephedrine, and Phenylpropanolamine.

(3)*Agency form number, if any and the applicable component of the Department sponsoring the collection:* *Form number:* DEA Form 189. *Component:* Office of Diversion Control, Drug Enforcement Administration, U.S. Department of Justice.

(4)*Affected public who will be asked or required to respond, as well as a brief abstract:* *Primary:* Business or other for-profit. *Other:* None. *Abstract:* 21 U.S.C. 826 and 21 CFR 1303.22 and 1315.22 require that any person who is registered to manufacture any basic class of controlled substances listed in Schedule I or II and who desires to manufacture a quantity of such class, or who desires to manufacture using the List I chemicals ephedrine, pseudoephedrine, or phenylpropanolamine, must apply on DEA Form 189 for a manufacturing quota for such quantity of such class or List I chemical.

(5)*An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond:* DEA estimates that each form takes 0.5 hours (30 minutes) to complete. In total, 37 firms submit 298 responses, with each response taking 0.5 hours (30 minutes) to complete. This results in a total public burden of 149 hours annually.

(6)*An estimate of the total public burden (in hours) associated with the collection:* In total, 37 firms submit 298 responses, with each response taking 0.5 hours (30 minutes) to complete. This results in a total public burden of 149 hours annually. *If additional information is required contact:* Lynn Bryant, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street, NW., Washington, DC 20530. Dated: August 20, 2007. Lynn Bryant, Department Clearance Officer, PRA, Department of Justice. [FR Doc. E7-16718 Filed 8-23-07; 8:45 am] BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117-0008] Agency Information Collection Activities: Proposed Collection; Comments Requested ACTION: 30-day notice of information collection under review: Application for procurement quota for controlled substances and ephedrine, pseudoephedrine, and phenylpropanolamine. The Department of Justice (DOJ), Drug Enforcement Administration

(DEA)will be submitting the following information collection request to the Office of Management and Budget

(OMB)for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the **Federal Register** Volume 72, Number 117, page 33775 on June 19, 2007, allowing for a 60-day comment period. The purpose of this notice is to allow for an additional 30 days for public comment until September 24, 2007. This process is conducted in accordance with 5 CFR 1320.10. Written comments and/or suggestions regarding the items contained in this notice, especially the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503. Additionally, comments may be submitted to OMB via facsimile to

(1)*Type of Information Collection:* Revision of an existing collection.

(2)*Title of the Form/Collection:* Application for Procurement Quota for Controlled Substances and Ephedrine, Pseudoephedrine, and Phenylpropanolamine.

(3)*Agency form number, if any and the applicable component of the Department sponsoring the collection:* *Form number:* DEA Form 250. *Component:* Office of Diversion Control, Drug Enforcement Administration, U.S. Department of Justice.

(4)*Affected public who will be asked or required to respond, as well as a brief abstract:* *Primary:* Business or other for-profit. *Other:* None. *Abstract:* 21 U.S.C. 826 and 21 CFR 1303.12 and 1315.32 require that U.S. companies who desire to use any basic class of controlled substances listed in Schedule I or II or the List I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for purposes of manufacturing during the next calendar year shall apply on DEA Form 250 for procurement quota for such class or List I chemical.

(5)*An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond:* DEA estimates that each form takes 1 hour to complete. DEA estimates that 240 individual respondents will respond to this form.

(6)*An estimate of the total public burden (in hours) associated with the collection:* 240 individual respondents will spend one hour annually completing this form for the List I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. This results in an annual public burden of 240 hours. This form is already used to collect information regarding controlled substances quotas. For that aspect of this collection, 255 respondents submit 1,106 responses annually, for a public burden of 1,106 hours annually. DEA notes that the controlled substances aspect of this collection is not being adjusted or revised. Therefore, the total public burden for this collection is 1,346 hours annually. *If additional information is required contact:* Lynn Bryant, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street, N.W., Washington, DC 20530. Dated: August 20, 2007. Lynn Bryant, Department Clearance Officer, PRA, Department of Justice. [FR Doc. E7-16790 Filed 8-23-07; 8:45 am] BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117-0043] Agency Information Collection Activities: Proposed Collection; Comments Requested ACTION: 60-day notice of information collection under review—drug questionnaire DEA Form 341. The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget

(OMB)for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted until October 23, 2007. This process is conducted in accordance with 5 CFR 1320.10. If you have comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Catherine J. Kasch, Assistant Administrator, Human Resources Division, Drug Enforcement Administration, Washington, DC 20537. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection

(1)*Type of Information Collection:* Extension of a currently approved collection.

(2)*Title of the Form/Collection:* Drug Questionnaire (DEA Form 341).

(3)*Agency form number, if any, and the applicable component of the Department sponsoring the collection:* *Form number:* DEA Form 341. *Component:* Human Resources Division, Drug Enforcement Administration, U.S. Department of Justice.

(4)*Affected public who will be asked or required to respond, as well as a brief abstract:* *Primary:* Individuals. *Other:* None. *Abstract:* DEA Policy states that a past history of illegal drug use may be a disqualification for employment with DEA. This form asks job applicants specific questions about their personal history, if any, of illegal drug use.

(5)*An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond:* It is estimated that 31,800 respondents will respond annually, taking 5 minutes to complete each form.

(6)*An estimate of the total public burden (in hours) associated with the collection:* 2,650 annual burden hours. *If additional information is required contact:* Lynn Bryant, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street, NW., Washington, DC 20530. Dated: August 20, 2007. Lynn Bryant, Department Clearance Officer, PRA, Department of Justice. [FR Doc. E7-16791 Filed 8-23-07; 8:45 am] BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [OMB Number 1117-0047] Agency Information Collection Activities: Proposed Collection; Comments Requested ACTION: 30-day notice of information collection under review: Application for import quota for ephedrine, pseudoephedrine, and phenylpropanolamine DEA Form 488. The Department of Justice (DOJ), Drug Enforcement Administration

(DEA)has submitted the following information collection request to the Office of Management and Budget

(OMB)for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. This proposed information collection was previously published in the **Federal Register** Volume 72, Number 117, page 33775 on June 19, 2007, allowing for a 60 day comment period. The purpose of this notice is to allow for an additional 30 days for public comment until September 24, 2007. This process is conducted in accordance with 5 CFR 1320.10. Written comments and/or suggestions regarding the items contained in this notice, especially the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503. Additionally, comments may be submitted to OMB via facsimile to

(1)*Type of Information Collection:* Extension of a currently approved collection.

(2)*Title of the Form/Collection:* Application for Import Quota for Ephedrine, Pseudoephedrine, and Phenylpropanolamine.

(3)*Agency form number, if any and the applicable component of the Department sponsoring the collection:* *Form number:* DEA Form 488. *Component:* Office of Diversion Control, Drug Enforcement Administration, U.S. Department of Justice.

(4)*Affected public who will be asked or required to respond, as well as a brief abstract:* *Primary:* Business or other for-profit. *Other:* None. *Abstract:* 21 U.S.C. 952 and 21 CFR 1315.34 require that persons who desire to import the List I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine during the next calendar year shall apply on DEA Form 488 for import quota for such List I chemicals.

(5)*An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond:* DEA estimates that ninety-one

(91)individual respondents will apply for import quotas. DEA estimates that each response will take one hour.

(6)*An estimate of the total public burden (in hours) associated with the collection:* DEA estimates that this collection will involve ninety-one

(91)annual public burden hours. *If additional information is required contact:* Lynn Bryant, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Patrick Henry Building, Suite 1600, 601 D Street NW, Washington, DC 20530. Dated: August 20, 2007. Lynn Bryant, Department Clearance Officer, PRA, Department of Justice. [FR Doc. E7-16792 Filed 8-23-07; 8:45 am] BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-307P] Controlled Substances: Proposed Aggregate Production Quotas for 2008 AGENCY: Drug Enforcement Administration (DEA), Justice. ACTION: Notice of proposed year 2008 aggregate production quotas. SUMMARY: This notice proposes initial year 2008 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA). DATES: Comments or objections must be received on or before September 14, 2007. ADDRESSES: To ensure proper handling of comments, please reference “Docket No. DEA-307P” on all written and electronic correspondence. Written comments being sent via regular mail should be sent to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative/ODL. Written comments sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson Davis Highway, Alexandria, VA 22301. Comments may be directly sent to DEA electronically by sending an electronic message to *dea.diversion.policy@usdoj.gov.* Comments may also be sent electronically through *http://www.regulations.gov* using the electronic comment form provided on that site. An electronic copy of this document is also available at the *http://www.regulations.gov* Web site. DEA will accept attachments to electronic comments in Microsoft Word, WordPerfect, Adobe PDF, or Excel file formats only. DEA will not accept any file format other than those specifically listed here. FOR FURTHER INFORMATION CONTACT: Christine A. Sannerud, PhD, Chief, Drug and Chemical Evaluation Section, Drug Enforcement Administration, Washington, DC 20537, Telephone:

(DOET)2 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) 10 3-Methylfentanyl 2 3-Methylthiofentanyl 2 3,4-Methylenedioxyamphetamine

(MDA)20 3,4-Methylenedioxy-N-ethylamphetamine

(MDEA)10 3,4-Methylenedioxymethamphetamine

(MDMA)22 3,4,5-Trimethoxyamphetamine 2 4-Bromo-2,5-dimethoxyamphetamine

(DOB)2 4-Bromo-2,5-dimethoxyphenethylamine (2-CB) 7 4-Methoxyamphetamine 77 4-Methylaminorex 2 4-Methyl-2,5-dimethoxyamphetamine

(DOM)12 5-Methoxy-3,4-methylenedioxyamphetamine 2 5-Methoxy-N,N-diisopropyltryptamine 5 Acetyl-alpha-methylfentanyl 2 Acetyldihydrocodeine 2 Acetylmethadol 2 Allylprodine 2 Alphacetylmethadol 2 Alpha-ethyltryptamine 2 Alphameprodine 2 Alphamethadol 3 Alpha-methylfentanyl 2 Alpha-methylthiofentanyl 2 Alpha-methyltryptamine 5 Aminorex 8 Benzylmorphine 2 Betacetylmethadol 2 Beta-hydroxy-3-methylfentanyl 2 Beta-hydroxyfentanyl 2 Betameprodine 2 Betamethadol 2 Betaprodine 2 Bufotenine 8 Cathinone 3 Codeine-N-oxide 302 Diethyltryptamine 2 Difenoxin 50 Dihydromorphine 2,549,000 Dimethyltryptamine 3 Gamma-hydroxybutyric acid 23,600,000 Heroin 5 Hydromorphinol 3,000 Hydroxypethidine 2 Ibogaine 1 Lysergic acid diethylamide

(LSD)61 Marihuana 4,500,000 Mescaline 2 Methaqualone 10 Methcathinone 4 Methyldihydromorphine 2 Morphine-N-oxide 310 N,N-Dimethylamphetamine 7 N-Ethylamphetamine 2 N-Hydroxy-3,4-methylenedioxyamphetamine 2 Noracymethadol 2 Norlevorphanol 52 Normethadone 2 Normorphine 16 Para-fluorofentanyl 2 Phenomorphan 2 Pholcodine 2 Psilocybin 7 Psilocyn 7 Tetrahydrocannabinols 312,500 Thiofentanyl 2 Trimeperidine 2 1-Phenylcyclohexylamine 2 Alfentanil 5,200 Alphaprodine 2 Amobarbital 3 Amphetamine (for sale) 17,000,000 Amphetamine (for conversion) 5,000,000 Cocaine 286,000 Codeine (for sale) 39,605,000 Codeine (for conversion) 59,000,000 Dextropropoxyphene 106,000,000 Dihydrocodeine 1,200,000 Diphenoxylate 828,000 Ecgonine 83,000 Ethylmorphine 2 Fentanyl 1,428,000 Glutethimide 2 Hydrocodone (for sale) 46,000,000 Hydrocodone (for conversion) 1,500,000 Hydromorphone 3,300,000 Isomethadone 2 Levo-alphacetylmethadol

(LAAM)3 Levomethorphan 5 Levorphanol 6,000 Lisdexamfetamine 6,200,000 Meperidine 9,753,000 Metazocine 1 Methadone (for sale) 25,000,000 Methadone Intermediate 26,000,000 Methamphetamine 3,130,000 Methylphenidate 50,000,000 Morphine (for sale) 35,000,000 Morphine (for conversion) 100,000,000 Nabilone 3,002 Noroxymorphone (for sale) 1,002 Noroxymorphone (for conversion) 8,000,000 Opium 1,400,000 Oxycodone (for sale) 70,000,000 Oxycodone (for conversion) 3,100,000 Oxymorphone 1,800,000 Oxymorphone (for conversion) 11,000,000 Pentobarbital 35,200,000 Phencyclidine 2,021 Phenmetrazine 2 Racemethorphan 2 Remifentanil 3,000 Secobarbital 2 Sufentanil 10,300 Thebaine 126,000,000 The Deputy Administrator further proposes that aggregate production quotas for all other schedules I and II controlled substances included in 21 CFR 1308.11 and 1308.12 be established at zero. All interested persons are invited to submit their comments in writing or electronically regarding this proposal following the procedures in the addresses section of this document. A person may object to or comment on the proposal relating to any of the above-mentioned substances without filing comments or objections regarding the others. If a person believes that one or more of these issues warrant a hearing, the individual should so state and summarize the reasons for this belief. In the event that comments or objections to this proposal raise one or more issues which the Deputy Administrator finds warrant a hearing, the Deputy Administrator shall order a public hearing by notice in the **Federal Register** , summarizing the issues to be heard and setting the time for the hearing. The Office of Management and Budget has determined that notices of aggregate production quotas are not subject to centralized review under Executive Order 12866. This action does not preempt or modify any provision of state law; nor does it impose enforcement responsibilities on any state; nor does it diminish the power of any state to enforce its own laws. Accordingly, this action does not have federalism implications warranting the application of Executive Order 13132. The Deputy Administrator hereby certifies that this action will have no significant impact upon small entities whose interests must be considered under the Regulatory Flexibility Act, 5 U.S.C. 601 *et seq.* The establishment of aggregate production quotas for schedules I and II controlled substances is mandated by law and by international treaty obligations. The quotas are necessary to provide for the estimated medical, scientific, research and industrial needs of the United States, for export requirements and the establishment and maintenance of reserve stocks. While aggregate production quotas are of primary importance to large manufacturers, their impact upon small entities is neither negative nor beneficial. Accordingly, the Deputy Administrator has determined that this action does not require a regulatory flexibility analysis. This action meets the applicable standards set forth in sections 3(a) and 3(b)(2) of Executive Order 12988 Civil Justice Reform. This action will not result in the expenditure by state, local, and tribal governments, in the aggregate, or by the private sector, of $120,000,000 or more in any one year, and will not significantly or uniquely affect small governments. Therefore, no actions were deemed necessary under the provisions of the Unfunded Mandates Reform Act of 1995. This action is not a major rule as defined by section 804 of the Small Business Regulatory Enforcement Fairness Act of 1996. This action will not result in an annual effect on the economy of $100,000,000 or more; a major increase in costs or prices; or significant adverse effects on competition, employment, investment, productivity, innovation, or on the ability of United States-based companies to compete with foreign-based companies in domestic and export markets. August 15, 2007. Michele M. Leonhart, Deputy Administrator. [FR Doc. E7-16729 Filed 8-23-07; 8:45 am] BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-290F] Controlled Substances: Final Revised Aggregate Production Quotas for 2007 AGENCY: Drug Enforcement Administration (DEA), Justice. ACTION: Notice of final aggregate production quotas for 2007. SUMMARY: This notice establishes final 2007 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA). The DEA has taken into consideration comments received in response to a notice of the proposed revised aggregate production quotas for 2007 published May 3, 2007 (72 FR 24608). EFFECTIVE DATE: August 24, 2007. FOR FURTHER INFORMATION CONTACT: Christine A. Sannerud, PhD, Chief, Drug and Chemical Evaluation Section, Drug Enforcement Administration, Washington, DC 20537, Telephone:

(202)307-7183. SUPPLEMENTARY INFORMATION: Section 306 of the CSA (21 U.S.C. 826) requires that the Attorney General establish aggregate production quotas for each basic class of controlled substance listed in schedules I and II. This responsibility has been delegated to the Administrator of the DEA by 28 CFR 0.100. The Administrator, in turn, has redelegated this function to the Deputy Administrator, pursuant to 28 CFR 0.104. The 2007 aggregate production quotas represent those quantities of controlled substances in schedules I and II that may be produced in the United States in 2007 to provide adequate supplies of each substance for: the estimated medical, scientific, research and industrial needs of the United States; lawful export requirements; and the establishment and maintenance of reserve stocks (21 U.S.C. 826(a) and 21 CFR 1303.11). These quotas do not include imports of controlled substances. On May 3, 2007, a notice of the proposed revised 2007 aggregate production quotas for certain controlled substances in schedules I and II was published in the **Federal Register** (72 FR 24608). All interested persons were invited to comment on or object to these proposed aggregate production quotas on or before May 24, 2007. Nine companies commented on a total of 31 schedules I and II controlled substances within the published comment period. Nine companies proposed that the aggregate production quotas for 14-hydroxymorphinone, alfentanil, amphetamine (for sale), amphetamine (for conversion), cocaine, codeine (for conversion), dextropropoxyphene, dihydromorphine, diphenoxylate, ecgonine, fentanyl, gamma hydroxybutyric acid, hydrocodone, hydromorphone, lisdexamfetamine, meperidine, methadone, methadone intermediate, methylphenidate, morphine, morphine (for conversion), nabilone, noroxymorphone (for conversion), oxycodone, oxymorphone, oxymorphone (for conversion), pentobarbital, remifentanil, sufentanil, tetrahydrocannabinols, and thebaine were insufficient to provide for the estimated medical, scientific, research, and industrial needs of the United States, for export requirements and for the establishment and maintenance of reserve stocks. The DEA has determined that the compound 14-hydroxymorphinone is a morphine derivative. The comment received concerning this substance was therefore, considered as a comment for morphine. DEA has taken into consideration the above comments along with the relevant 2006 year-end inventories, initial 2007 manufacturing quotas, 2007 export requirements, actual and projected 2007 sales, research, product development requirements and additional applications received. Based on this information, the DEA has adjusted the final 2007 aggregate production quotas for 2,5-dimethoxyamphetamine, alfentanil, amphetamine (for conversion), gamma-hydroxybutyric acid, hydrocodone, methylphenidate, oxycodone, oxycodone (for conversion), pentobarbital, remifentanil, sufentanil and thebaine to meet the legitimate needs of the United States. Regarding amphetamine (for sale), cocaine, codeine (for conversion), dextropropoxyphene, dihydromorphine, diphenoxylate, ecgonine, fentanyl, hydromorphone, lisdexamfetamine, meperidine, methadone, methadone intermediate, morphine, morphine (for conversion), nabilone, noroxymorphone (for conversion), oxymorphone, oxymorphone (for conversion), and tetrahydrocannabinols the DEA has determined that the proposed revised 2007 aggregate production quotas are sufficient to meet the current 2007 estimated medical, scientific, research, and industrial needs of the United States and to provide for adequate inventories. Therefore, under the authority vested in the Attorney General by section 306 of the CSA (21 U.S.C. 826), and delegated to the Administrator of the DEA by 28 CFR 0.100, and redelegated to the Deputy Administrator, pursuant to 28 CFR 0.104, the Deputy Administrator hereby orders that the 2007 final aggregate production quotas for the following controlled substances, expressed in grams of anhydrous acid or base, be established as follows: Basic class—Schedule I Final revised 2007 quotas (grams) 2,5-Dimethoxyamphetamine 2 2,5-Dimethoxy-4-ethylamphetamine

(DOET)2 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) 10 3-Methylfentanyl 2 3-Methylthiofentanyl 2 3,4-Methylenedioxyamphetamine

(MDA)20 3,4-Methylenedioxy-N-ethylamphetamine

(MDEA)10 3,4-Methylenedioxymethamphetamine

(MDMA)22 3,4,5-Trimethoxyamphetamine 2 4-Bromo-2,5-dimethoxyamphetamine

(DOB)2 4-Bromo-2,5-dimethoxyphenethylamine (2-CB) 7 4-Methoxyamphetamine 77 4-Methylaminorex 2 4-Methyl-2,5-dimethoxyamphetamine

(LSD)61 Marihuana 4,500,000 Mescaline 2 Methaqualone 10 Methcathinone 4 Methyldihydromorphine 2 Morphine-N-oxide 310 N,N-Dimethylamphetamine 7 N-Ethylamphetamine 2 N-Hydroxy-3,4-methylenedioxyamphetamine 2 Noracymethadol 2 Norlevorphanol 52 Normethadone 2 Normorphine 16 Para-fluorofentanyl 2 Phenomorphan 2 Pholcodine 2 Psilocybin 7 Psilocyn 7 Tetrahydrocannabinols 312,500 Thiofentanyl 2 Trimeperidine 2 Basic class—Schedule II Final revised 2007 quotas (grams) 1-Phenylcyclohexylamine 2 Alfentanil 5,200 Alphaprodine 2 Amobarbital 3 Amphetamine (for sale) 17,000,000 Amphetamine (for conversion) 5,000,000 Cocaine 286,000 Codeine (for sale) 39,605,000 Codeine (for conversion) 59,000,000 Dextropropoxyphene 120,000,000 Dihydrocodeine 2,435,000 Diphenoxylate 828,000 Ecgonine 83,000 Ethylmorphine 2 Fentanyl 1,428,000 Glutethimide 2 Hydrocodone (for sale) 46,000,000 Hydrocodone (for conversion) 1,500,000 Hydromorphone 3,300,000 Isomethadone 2 Levo-alphacetylmethadol

(LAAM)6 Levomethorphan 5 Levorphanol 6,000 Lisdexamfetamine 6,200,000 Meperidine 9,753,000 Metazocine 1 Methadone (for sale) 25,000,000 Methadone Intermediate 26,000,000 Methamphetamine 3,130,000 Methylphenidate 50,000,000 Morphine (for sale) 35,000,000 Morphine (for conversion) 110,774,000 Nabilone 3,002 Noroxymorphone (for sale) 1,002 Noroxymorphone (for conversion) 11,000,000 Opium 1,400,000 Oxycodone (for sale) 70,000,000 Oxycodone (for conversion) 3,100,000 Oxymorphone 1,800,000 Oxymorphone (for conversion) 15,300,000 Pentobarbital 35,200,000 Phencyclidine 2,021 Phenmetrazine 2 Racemethorphan 2 Remifentanil 3,000 Secobarbital 2 Sufentanil 10,300 Thebaine 126,000,000 The Deputy Administrator further orders that the aggregate production quotas for all other schedules I and II controlled substances included in 21 CFR 1308.11 and 1308.12 shall be zero. The Office of Management and Budget has determined that notices of aggregate production quotas are not subject to centralized review under Executive Order 12866. This action does not preempt or modify any provision of state law; nor does it impose enforcement responsibilities on any state; nor does it diminish the power of any state to enforce its own laws. Accordingly, this action does not have federalism implications warranting the application of Executive Order 13132. The Deputy Administrator hereby certifies that this action will have no significant impact upon small entities whose interests must be considered under the Regulatory Flexibility Act, 5 U.S.C. 601 *et seq.* The establishment of aggregate production quotas for schedules I and II controlled substances is mandated by law and by international treaty obligations. The quotas are necessary to provide for the estimated medical, scientific, research and industrial needs of the United States, for export requirements and the establishment and maintenance of reserve stocks. While aggregate production quotas are of primary importance to large manufacturers, their impact upon small entities is neither negative nor beneficial. Accordingly, the Deputy Administrator has determined that this action does not require a regulatory flexibility analysis. This action meets the applicable standards set forth in sections 3(a) and 3(b)(2) of Executive Order 12988 Civil Justice Reform. This action will not result in the expenditure by state, local, and tribal governments, in the aggregate or by the private sector, of $120,000,000 or more in any one year, and will not significantly or uniquely affect small governments. Therefore, no actions were deemed necessary under the provisions of the Unfunded Mandates Reform Act of 1995. This action is not a major rule as defined by section 804 of the Small Business Regulatory Enforcement Fairness Act of 1996. This action will not result in an annual effect on the economy of $100,000,000 or more; a major increase in costs or prices; or significant adverse effects on competition, employment, investment, productivity, innovation, or on the ability of United States-based companies to compete with foreign-based companies in domestic and export markets. Dated: August 15, 2007. Michele M. Leonhart, Deputy Administrator. [FR Doc. E7-16730 Filed 8-23-07; 8:45 am] BILLING CODE 4410-09-P DEPARTMENT OF LABOR Employment and Training Administration Agency Information Collection Activities: Revision and Extension of a Currently Approved Information Collection; Comment Request ACTION: 60-day notice of information collection under review: Application for Permanent Employment Certification; Form ETA-9089, OMB Control No. 1205-0451. SUMMARY: The Department of Labor, as part of its continuing effort to reduce paperwork and respondent burden, is conducting a pre-clearance consultation to provide the general public and Federal agencies with an opportunity to comment on proposed and/or continuing collections of information in accordance with the Paperwork Reduction Act of 1995 (PRA95) [44 U.S.C. 3506(c)(2)(A)]. This consultation is undertaken to ensure that requested data can be provided in the desired format, reporting burden (time and financial resources) is minimized, collection instruments are clearly understood, and the impact of collection requirements on respondents can be properly assessed. Currently, the Employment and Training Administration is soliciting comments concerning Form ETA 9089 Application for Permanent Employment Certification. A copy of the proposed information collection request

(ICR)can be obtained by contacting the office listed below in the addressee section of this notice or at this Web site: *http://www.doleta.gov/OMBCN/OMBControlNumber.cfm.* DATES: Written comments must be submitted to the office listed in the addressee section below on or before October 23, 2007. ADDRESSES: William L. Carlson, Administrator, Office of Foreign Labor Certification, U.S. Department of Labor, Room C4312, 200 Constitution Ave., NW., Washington, DC 20210. Phone

(202)693-3010 (This is not a toll-free number.), fax

(202)693-2768, or e-mail at *ETA.OFLC.Forms@dol.gov* subject line: Form ETA 9089. SUPPLEMENTARY INFORMATION: I. Background The information collection is required by sections 203(b)(3) and 212(a)(5)(A) of the Immigration and Nationality Act

(INA)(8 U.S.C. 1153(b)(3) and 1182(a)(5)(A)). The Department of Labor (Department) and the Department of Homeland Security

(DHS)have promulgated regulations to implement the INA. Specifically for this collection, Title 20 CFR 656 and Title 8 CFR 204.5 are applicable. The INA mandates the Secretary of Labor to certify that any alien seeking to enter the United States for the purpose of performing skilled or unskilled labor is not adversely affecting wages and working conditions of U.S. workers similarly employed and that there are not sufficient U.S. workers able, willing, and qualified to perform such skilled or unskilled labor. Before any employer may request any skilled or unskilled alien labor, it must submit a request for certification to the Secretary of Labor containing the elements prescribed by the INA and the CFR. The CFR requires employers to document their recruitment efforts and substantiate the reasons no U.S. workers were hired. II. Review Focus The Department of Labor is particularly interested in comments which: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; • Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses. III. Current Actions In order to meet its statutory responsibilities under the INA, the Department needs to extend an existing collection of information pertaining to employers seeking to apply for permanent employment certification to allow them to bring foreign labor to the United States on a permanent basis. Extensive program experience, in particular since its reengineering in 2005, has demonstrated the need for further clarification on this information collection and has shown that changes to the collection are also necessary. In the past the respondents have been for-profit businesses, not-for-profit institutions, individuals, households, and farms. On rare occasions the respondents have been local, state, tribal governments, or the federal government. The Secretary of Labor uses the collected information to determine if allowing an alien to enter the United States for the purpose of performing skilled or unskilled labor will adversely affect wages and working conditions of U.S. workers similarly employed and whether or not there were sufficient U.S. workers able, willing, and qualified to perform such skilled or unskilled labor at the time of the application. Changes are being proposed to ETA Form 9089 for two reasons. The first is to provide more clarity to the user of the form, thereby obtaining more accurate information for the Department to assist in more efficient and effective adjudication of the requested benefit. The second is to implement amendments required by the Final Rule published in the **Federal Register** May 17, 2007: Labor Certification for the Permanent Employment of Aliens in the United States; Reducing the Incentives and Opportunities for Fraud and Abuse and Enhancing Program Integrity. *Type of Review:* Revision and Extension of Currently Approved Information Collection. *Agency:* Employment and Training Administration. *Title:* Application for Permanent Employment Certification. *OMB Control No.:* 1205-0451. *Agency Number(s):* Form ETA 9089. *Recordkeeping:* On occasion. *Affected Public:* Businesses or other for-profits and not-for-profits, individuals or households, farms, and Federal, State, Local or Tribal Governments. *Total Respondents:* 120,000. *Estimated Total Burden Hours:* 342,686. *Total Burden Cost (capital/startup):* 0. *Total Burden Cost (operating/maintaining):* $2,500,000. Comments submitted in response to this comment request will be summarized and/or included in the request for Office of Management and Budget approval of the information collection request; they will also become a matter of public record. Dated: August 14, 2007. William L. Carlson, Administrator, Office of Foreign Labor Certification. [FR Doc. E7-16800 Filed 8-23-07; 8:45 am] BILLING CODE 4510-FP-P DEPARTMENT OF LABOR Employment and Training Administration Request for Certification of Compliance—Rural Industrialization Loan and Grant Program AGENCY: Employment and Training Administration, Labor. ACTION: Notice. SUMMARY: The Employment and Training Administration is issuing this notice to announce the receipt of a “Certification of Non-Relocation and Market and Capacity Information Report” (Form 4279-2) for the following: Applicant/Location: Rock Springs Mineral Processing, Inc./Arminto, Wyoming. Principal Product: The loan, guarantee, or grant application is for a new business venture to construct a plant to process bentonite products. The NAICS industry code for this enterprise is: 212325 Clay and Ceramic and Refractory Minerals Mining. DATES: All interested parties may submit comments in writing no later than September 7, 2007. Copies of adverse comments received will be forwarded to the applicant noted above. ADDRESSES: Address all comments concerning this notice to Anthony D. Dais, U.S. Department of Labor, Employment and Training Administration, 200 Constitution Avenue, NW., Room S-4231, Washington, DC 20210; or e-mail *Dais.Anthony@dol.gov;* or transmit via fax 202-693-3015 (this is not a toll-free number). FOR FURTHER INFORMATION CONTACT: Anthony D. Dais, at telephone number

(202)693-2784 (this is not a toll-free number). SUPPLEMENTARY INFORMATION: Section 188 of the Consolidated Farm and Rural Development Act of 1972, as established under 29 CFR Part 75, authorizes the United States Department of Agriculture to make or guarantee loans or grants to finance industrial and business activities in rural areas. The Secretary of Labor must review the application for financial assistance for the purpose of certifying to the Secretary of Agriculture that the assistance is not calculated, or likely, to result in:

(a)A transfer of any employment or business activity from one area to another by the loan applicant's business operation; or,

(b)an increase in the production of goods, materials, services, or facilities in an area where there is not sufficient demand to employ the efficient capacity of existing competitive enterprises unless the financial assistance will not have an adverse impact on existing competitive enterprises in the area. The Employment and Training Administration within the Department of Labor is responsible for the review and certification process. Comments should address the two bases for certification and, if possible, provide data to assist in the analysis of these issues. Signed at: Washington, DC this 20th day of August, 2007. Gay M. Gilbert, Administrator, Office of Workforce Investment, Employment and Training Administration. [FR Doc. E7-16704 Filed 8-23-07; 8:45 am] BILLING CODE 4510-FN-P MILLENNIUM CHALLENGE CORPORATION [MCC FR 07-09] Report on Countries That Are Candidates for Millennium Challenge Account Eligibility in Fiscal Year 2008 and Countries That Would Be Candidates but for Legal Prohibitions AGENCY: Millennium Challenge Corporation. ACTION: Notice. SUMMARY: Section 608(d) of the Millennium Challenge Act of 2003 requires the Millennium Challenge Corporation to publish a report that identifies countries that are “candidate countries” for Millennium Challenge Account assistance during FY 2008. The report is set forth in full below. Report on Countries That Are Candidates for Millennium Challenge Account Eligibility for Fiscal Year 2008 and Countries That Would Be Candidates but for Legal Prohibitions This report to Congress is provided in accordance with section 608(a) of the Millennium Challenge Act of 2003, 22 U.S.C. 7701, 7707(a) (Act). The Act authorizes the provision of Millennium Challenge Account

(MCA)assistance to countries that enter into Compacts with the United States to support policies and programs that advance the progress of such countries achieving lasting economic growth and poverty reduction. The Act requires Millennium Challenge Corporation

(MCC)to take a number of steps in determining the countries that will be eligible for MCA assistance for Fiscal Year

(FY)2008 based on a country's demonstrated commitment to

(i)Just and democratic governance,

(ii)economic freedom and investing in their people, and

(iii)the opportunity to reduce poverty and generate economic growth in the country. These steps include the submission of reports to the congressional committees specified in the Act and the publication of notices in the **Federal Register** that identify: 1. The countries that are “candidate countries” for MCA assistance for FY 2008 based on their per-capita income levels and their eligibility to receive assistance under U.S. law and countries that would be candidate countries but for specified legal prohibitions on assistance (Section 608(a) of the Act); 2. The criteria and methodology that the MCC Board of Directors (Board) will use to measure and evaluate the relative policy performance of the “candidate countries” consistent with the requirements of subsections

(a)and

(b)of section 607 of the Act in order to select “MCA eligible countries” from among the “candidate countries” (Section 608(b) of the Act); and 3. The list of countries determined by the Board to be “MCA eligible countries” for FY 2008, with a justification for such eligibility determination and selection for compact negotiation, including which of the MCA eligible countries the Board will seek to enter into MCA Compacts (Section 608(d) of the Act). This report is the first of three required reports listed above. Candidate Countries for FY 2008 The Act requires the identification of all countries that are candidates for MCA assistance for FY 2008 and the identification of all countries that would be candidate countries but for specified legal prohibitions on assistance. Sections 606(a) and

(b)of the Act provide that for FY 2008 a country shall be a candidate for the MCA if it: • Meets one of the following two income level tests: ○ Has a per capita income equal to or less than the historical ceiling of the International Development Association eligibility for the fiscal year involved (or $1,735 gross national income

(GNI)per capita for FY 2008) (the “low income category”); or ○ Is classified as a lower middle income country in the then most recent edition of the World Development Report for Reconstruction and Development published by the International Bank for Reconstruction and Development and has an income greater than the historical ceiling for International Development Association eligibility for the fiscal year involved (or $1,736 to $3,595 GNI per capita for FY 2008) (the “lower middle income category”); and • Is not ineligible to receive U.S. economic assistance under Part I of the Foreign Assistance Act of 1961, as amended, (the “Foreign Assistance Act”), by reason of the application of the Foreign Assistance Act or any other provision of law. Pursuant to section 606(c) of the Act, the Board has identified the following countries as candidate countries under the Act for FY 2008. In so doing, the Board has anticipated that prohibitions against assistance as applied to countries in the Foreign Operations, Export Financing, and Related Programs Appropriations Act, 2006 (P.L. 109-102) (FY 2006 FOAA), as carried forward for FY 2007 by the Revised Continuing Appropriations Resolution, 2007 (P.L. 110-5) (FY 2007 CR), will again apply for FY 2008, even though the Foreign Operations, Export Financing and Related Programs Appropriations Act for FY 2008 has not yet been enacted and certain findings under other statutes have not yet been made. As noted below, MCC will provide any required updates on subsequent changes in applicable legislation or other circumstances that affects the status of any country as a candidate country for FY 2008. Candidate Countries: Low Income Category 1. Afghanistan. 2. Bangladesh. 3. Benin. 4. Bhutan. 5. Bolivia. 6. Burkina Faso. 7. Burundi. 8. Cambodia. 9. Cameroon. 10. Central African Republic. 11. Chad. 12. Comoros. 13. Congo, Democratic Republic of the. 14. Congo, Republic of the. 15. Djibouti. 16. Egypt. 17. Eritrea. 18. Ethiopia. 19. Gambia, The. 20. Georgia. 21. Ghana. 22. Guinea. 23. Guinea-Bissau. 24. Guyana. 25. Haiti. 26. Honduras. 27. India. 28. Indonesia. 29. Iraq. 30. Kenya. 31. Kiribati. 32. Kyrgyzstan. 33. Laos. 34. Lesotho. 35. Liberia. 36. Madagascar. 37. Malawi. 38. Mali. 39. Mauritania. 40. Moldova. 41. Mongolia. 42. Mozambique. 43. Nepal. 44. Nicaragua. 45. Niger. 46. Nigeria. 47. Pakistan. 48. Papua New Guinea. 49. Paraguay. 50. Philippines. 51. Rwanda. 52. Sao Tome and Principe. 53. Senegal 54. Sierra Leone 55. Solomon Islands 56. Somalia. 57. Sri Lanka. 58. Tajikistan. 59. Tanzania. 60. Timor-Leste. 61. Togo. 62. Turkmenistan. 63. Uganda. 64. Vanuatu. 65. Vietnam. 66. Yemen. 67. Zambia. Candidate Countries: Lower Middle Income Category 1. Albania. 2. Algeria. 3. Angola. 4. Armenia. 5. Azerbaijan. 6. Belarus. 7. Cape Verde. 8. Colombia. 9. Dominican Republic. 10. Ecuador. 11. El Salvador. 12. Guatemala. 13. Jamaica. 14. Jordan. 15. Macedonia. 16. Maldives. 17. Marshall Islands. 18. Micronesia, Federated States of. 19. Morocco. 20. Namibia. 21. Peru. 22. Samoa. 23. Suriname. 24. Swaziland. 25. Tonga. 26. Tunisia. 27. Tuvalu. 28. Ukraine. Countries That Would Be Candidate Countries but for Legal Prohibitions That Prohibit Assistance Countries that would be considered candidate countries for FY 2008, but are ineligible to receive United States economic assistance under Part I of the Foreign Assistance Act by reason of the application of any provision of the Foreign Assistance Act or any other provision of law are listed below. As noted above, this list is based on legal prohibitions against economic assistance that apply for FY 2007 and that are anticipated to apply again for FY 2008. Prohibited Countries: Low Income Category 1. Burma is subject to numerous restrictions, including but not limited to section 570 of the FY 1997 Foreign Operations, Export Financing, and Related Programs Appropriations Act (P.L. 104-208) which prohibits assistance to the government of Burma until it makes progress on improving human rights and implementing democratic government, and due to its status as a major drug-transit or major illicit drug producing country for 2006 (Presidential Determination No. 2006-24 (9/15/2006)) and a Tier III country under the Trafficking Victims Protection Act (Presidential Determination No. 2006-25 (9/26/2006)). 2. The Cote d'Ivoire is subject to Section 508 of the FY 2006 FOAA, as carried forward by the FY 2007 CR, which prohibits assistance to the government of a country whose duly elected head of government is deposed by military coup or decree. 3. Cuba is subject to numerous restrictions, including but not limited to Section 620A of the Foreign Assistance Act which prohibits assistance to governments supporting international terrorism, provisions of the Cuban Liberty and Democratic Solidarity Act of 1996 (P.L. 104-114), and Section 507 of the FY 2006 FOAA, as carried forward by the FY 2007 CR. 4. North Korea is subject to numerous restrictions, including but not limited to section 620A of the Foreign Assistance Act which prohibits assistance to governments supporting international terrorism and Section 507 of the FY 2006 FOAA, as carried forward by the FY 2007 CR. 5. Sudan is subject to numerous restrictions, including but not limited to Section 620A of the Foreign Assistance Act which prohibits assistance to governments supporting international terrorism, Section 512 of the FY 2006 FOAA, as carried forward by the FY 2007 CR, and section 620(q) of the Foreign Assistance Act, both of which prohibit assistance to countries in default in payment to the U.S. in certain circumstances, section 508 of the FY 2006 FOAA, as carried forward by the FY 2007 CR, which prohibits assistance to a country whose duly elected head of government being deposed by military coup or decree, and section 569 of the FY 2006 FOAA, as carried forward by the FY 2007 CR. 6. Syria is subject to numerous restrictions, including but not limited to 620A of the Foreign Assistance Act which prohibits assistance to governments supporting international terrorism, sections 507 and 512 of the FY 2006 FOAA, as carried forward by the FY 2007 CR, and section 620(q) of the Foreign Assistance Act which prohibit assistance to countries in default in payment to the U.S. in certain circumstances. 7. Uzbekistan's central government is subject to section 586 of the FY 2006 FOAA, as carried forward by the FY 2007 CR, which requires that funds appropriated for assistance to the central government of Uzbekistan may be made available only if the Secretary of State determines and reports to the Congress that the government is making substantial and continuing progress in meeting its commitments under a framework agreement with the United States. 8. Zimbabwe is subject to section 620(q) of the Foreign Assistance Act and section 512 of the FY 2006 FOAA, as carried forward by the FY 2007 CR, which prohibit assistance to countries in default in payment to the United States in certain circumstances. Prohibited Countries: Lower Middle Income Category 1. Republika Srpska, which is part of the country of Bosnia and Herzegovina, is subject to section 561 of the FY 2006 FOAA, as carried forward by the FY 2007 CR, which prohibits assistance to any country, entity, or municipality whose competent authorities have failed, as determined by the Secretary of State, to take necessary and significant steps to implement its international legal obligations with respect to the International Criminal Tribunal for the former Yugoslavia. 2. China is not eligible to receive economic assistance from the United States, absent special authority, because of concerns relative to China's record on human rights. 3. The Fiji Islands are subject to section 508 of the FY 2006 FOAA, as carried forward by the FY 2007 CR, which prohibits assistance to the government of a country whose duly elected government is deposed by military coup or decree. 4. Iran is subject to numerous restrictions, including but not limited to Section 620A of the Foreign Assistance Act which prohibits assistance to governments supporting international terrorism and section 507 of the FY 2006 FOAA, as carried forward by the FY 2007 CR. 5. Thailand is subject to section 508 of the FY 2006 FOAA, as carried forward by the FY 2007 CR, which prohibits assistance to the government of a country whose duly elected government is deposed by military coup or decree. Countries identified above as candidate countries, as well as countries that would be considered candidate countries but for the applicability of legal provisions that prohibit U.S. economic assistance, may be the subject of future statutory restrictions or determinations, or changed country circumstances, that affect their legal eligibility for assistance under Part I of the Foreign Assistance Act by reason of application of Foreign Assistance Act or any other provision of law for FY 2008. MCC will include any required updates on such statutory eligibility that affect countries' identification as candidate countries for FY 2008, at such time as it publishes the Notices required by sections 608(b) and 608(d) of the Act or at other appropriate times. Any such updates with regard to the legal eligibility or ineligibility of particular countries identified in this report will not affect the date on which the Board is authorized to determine eligible countries from among candidate countries which, in accordance with section 608(a) of the Act, shall be no sooner than 90 days from the date of publication of this report. Dated: August 20, 2007. Henry Pitney, Acting General Counsel, Millennium Challenge Corporation. [FR Doc. E7-16723 Filed 8-23-07; 8:45 am] BILLING CODE 9211-03-P NATIONAL SCIENCE FOUNDATION Agency Information Collection Activities: Comment Request; Generic Survey Clearance for the Directorate of Education and Human Resources

(EHR)AGENCY: National Science Foundation. ACTION: Notice. SUMMARY: The National Science Foundation

(NSF)is announcing plans to request renewed clearance of this collection. In accordance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, we are providing opportunity for public comment on this action. After obtaining and considering public comment, NSF will prepare the submission requesting OMB clearance of this collection for no longer than 3 years. Comments are invited on:

(a)Whether the proposed collection of information is necessary for the proper performance of the functions of the Agency, including whether the information shall have practical utility;

(b)the accuracy of the Agency's estimate of the burden of the proposed collection of information;

(c)ways to enhance the quality, utility, and clarity of the information on respondents, including through the use of automated collection techniques or other forms of information technology; and

(d)ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. DATES: Written comments should be received by October 23, 2007 to be assured of consideration. Comments received after that date will be considered to the extent practicable. ADDRESSES: Written comments regarding the information collection and requests for copies of the proposed information collection request should be addressed to Suzanne Plimpton, Reports Clearance Officer, National Science Foundation, 4201 Wilson Blvd., Rm. 295, Arlington, VA 22030, or by e-mail to *splimpto@nsf.gov.* FOR FURTHER INFORMATION CONTACT: Suzanne Plimpton on

(703)292-7556 or send e-mail to *splimpto@nsf.gov.* Individuals who use a telecommunications device for the deaf

(TDD)may call the Federal Information Relay Service

(FIRS)at 1-800-877-8339 between 8 a.m. and 8 p.m., Eastern time, Monday through Friday. SUPPLEMENTARY INFORMATION: *Title of Collection:* EHR Generic Clearance. *OMB Approval Number:* 3145-0136. *Expiration Date of Approval:* January 31, 2008. *Abstract:* The National Science Foundation

(NSF)requests renewal of program accountability and communication data collections (e.g., surveys, face-to-face and telephone interviews, observations, and focus groups) that describe and track the impact of NSF funding that focuses on the Nation's science, technology, engineering and mathematics

(STEM)education and STEM workforce. NSF funds grants, contracts, and cooperative agreements to colleges, universities, and other eligible institutions, and provides graduate research fellowships to individuals in all parts of the United States and internationally. The Directorate for Education and Human Resources (EHR), a unit within NSF, promotes rigor and vitality within the Nation's STEM education enterprise to further the development of the 21st century's STEM workforce and public scientific literacy. EHR does this through diverse projects and programs that support research, extension, outreach, and hands-on activities service STEM learning and research at all institutional (e.g., pre-school through postdoctoral) levels in formal and informal settings; and individuals of all ages (birth and beyond). EHR also focuses on broadening participation in STEM learning and careers among United STates citizens, permanent residents and nationals, particularly those individuals traditionally underemployed in the STEM research workforce, including but not limited to women, persons with disabilities, and racial and ethnic minorities. At the request of the Office of Management and Budget

(OMB)an EHR Generic Clearance was established in 1995 to integrate management, monitoring and evaluation information pertaining to the NSF's Education and Training (E&T) portfolio in response to the Government Performance and Results Acts

(GPRA)of 1993. Under this generic survey clearance (OMB 3145-0136), data from the NSF administrative databases are incorporated with findings gathered through initiative-, divisional-, and program-specific data collections. The scope of the EHR Generic Clearance primarily covers descriptive information gathered from education and training projects that are funded by NSF. Most programs subject to EHR Generic data collection are funded by the EHR Directorate, but some are funded in whole or in part by disciplinary directorates or multi-disciplinary or cross-cutting programs. Since 2001 in accordance with OMB's Terms of Clearance, NSF primarily uses the data from the EHR Generic Clearance for program planning, management and audit purposes to respond to queries from the Congress, the public, NSF's external merit reviewers who serve as advisors, including Committees of Visitors, and the NSF's Office of the Inspector General. OMB has limited the collection to three categories of descriptive data:

(1)Staff and project participants (data that are also necessary to determine individual-level treatment and control groups for future third-party study);

(2)project implementation characteristics (also necessary for future use to identify well-matched comparison groups) and

(3)project outputs (necessary to measure baseline for pre- and post- NSF-funding-level impacts). *Use of the Information:* This information is required for effective administration, communication, program and project monitoring and evaluation, and for measuring attainment of NSF's program, project and strategic goals, as required by the President's Management agenda as represented by the Office of Management and Budget's

(OMB)Program Assessment Rating Tool (PART); the Deficit Reduction Act of 2005 (Pub. L. 109-171) which established the Academic Competitiveness (ACC), and the NSF's Strategic Plan. The Foundation's FY 2006-2011 Strategic Plan describes four strategic outcome goals of Discovery, Learning, Research Infrastructure, and Stewardship. NSF's complete strategic plan may be found at: *http://www.nsf.gov/publications/pub_summ.jsp?ods_key=nsf0648.* The work of the multi-agency ACC employed a methodological framework to determine STEM education program effectiveness. The ACC was chaired by the Department of Education and other agencies that participated included the NSF and the National Aeronautics and Space Administration (NASA). The ACC suggested cross-agency STEM education goals and metrics and developed a framework or “Hierarchy of Study Designs” under three scientific categories:

(1)Experimental (often called randomized controlled trails—RCT)

(2)quasi-experimental (such as well-matched comparison group studies) and

(3)other (such as pre and post-test and multiple methodologies). Further details on the participating agencies and the ACC's recommendations are available at: *http://www.ed.gov/about/inits/ed/competitiveness/acc-matchscience/index.html.* Since the EHR Generic Clearance research is primarily used for accountability purposes, including responding from queries from Committees of Visitors and other scientific experts, a census rather than sampling design typically is necessary. At the individual project level funding can be adjusted based on individual project's responses to some of the surveys. Some data collected under the EHR Clearance serve as baseline data for separate research and evaluation studies. The EHR Generic Clearance may be used to clear data collections for other ACC agencies, such as NASA. In February 2007 NASA and NSF signed a *Memorandum of Understanding (MOU)* to coordinate efforts promoting STEM education, the participation of individuals underrepresented in STEM, and evaluation of STEM education projects and programs in formal and informal settings. Additional information on the NSF-NASA MOU can be found at: *http://education.nasa.gov/divisions /higher/overview/F_One_Giant_Step_STEM_Education.html.* In order to conduct program or portfolio level evaluations, however, both experimental and quasi-experimental evaluation research studies on STEM education interventions require researchers to identify individual-level and organization or project-level control and treatment groups or comparison groups. NSF-funded contract or grantee researchers and evaluators in part may identify control, comparison, or treatment groups for NSF's E&T portfolio using some of the descriptive data gathered through OMB 3145-0136 to conduct well-designed, rigorous research and portfolio evaluation studies. In accordance with the 2001 and 2005 OMB terms of clearance, NSF requests separate stand-alone clearance (and separately announces for comment in the **Federal Register** any program or portfolio research or evaluation. Two examples of third-party evaluations that used EHR OMB 3145-0136 data to inform study design are: OMB 3145-0190 (Expired: 5/2005) Evaluation of NSF's Louis Stokes Alliances for Minority Participation (LSAMP) program conducted by the Urban Institute and OMB No. 3145-0182 (Expired 7/2005) Evaluation of the Initial Impacts of the Integrative Graduate Education Research and Traineeship (IGERT) program conducted by Abt Associates. For more information on these and other NSF-funded evaluations, please see the NSF's FY 2006 Full Performance and Accountability Report: Appendix 4 B: Table of External Evaluations at: * http:// www.nsf.gov/pubs/2007/nsf0701/pdf/19.pdf. * *Respondents:* Individuals or households, not-for-profit institutions, business or other for profit, and Federal, State, local or tribal government. *Number of Respondents:* 27,000. *Burden of the Public:* The total estimate for this collection is 60,000 annual burden hours. This figure is based on the previous 3 years of collecting information under this clearance and anticipated collections. The average annual reporting burden is between .5 and 50 hours per “respondent” depending on whether a respondent is a direct participant who is self-reporting or representing a project and reporting on behalf of many project participants. Dated: August 20, 2007. Suzanne H. Plimpton, Reports Clearance Officer, National Science Foundation. [FR Doc. 07-4141 Filed 8-23-07; 8:45 am]

Connectionstraces to 15

Traces to 15 documents

U.S. Code

CFR

7 references not yet in our index

5 CFR 1320.10
21 CFR 1303.12
21 CFR 1303
20 CFR 656
8 CFR 204.5
29 CFR 75
Pub. L. 109-171

Citation graph

cites case law

Notices

30-day notice of information collection under review: Application for individual manufacturing quota for a basic class of controlled substance and for ephedrine, pseudoephedrine, and phenylpropanolamine DEA Form189

Fed. Reg.Proposed Rules

Cite5 CFR 1320.10

Cite21 CFR 1303.12

Cite21 CFR 1303

Cites 22 · showing 12Cited by 0 across 0 sources